Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
NCT00000698Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of ganciclovir in cytomegalovirus retinitis, sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
ganciclovir
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT00000698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000698.